Key result
This review summarizes current guidelines from major societies on screening for coronary heart disease in patients with diabetes and detecting metabolic diseases in patients with coronary heart disease.
This review summarizes current guidelines for screening coronary heart disease in diabetic patients and metabolic diseases in CHD patients.
Consolidates major society guidelines on bidirectional screening; leaves open whether adherence improves outcomes in diverse populations.
Diabetes and cardiovascular disease are so intertwined with one another that the presence of one prompts a search for the other. Diabetes has been considered to be equivalent to coronary heart disease (CHD), and conversely many patients with known CHD have concomitant diabetes or its pre-states. This review has been compiled based on the guidelines of the American Diabetes Association, the Third Report of the National Cholesterol Education Program Adult Treatment Panel (NCEP ATP III), the European Society of Cardiology, and the European Association for the Study of Diabetes. A systematic approach was developed by the European Society of Cardiology and the European Association for the Study of Diabetes recently to help detect CHD in patients with diabetes and to detect metabolic diseases in patients with CHD.This article is intended for the clinician in everyday practice focusing on the impact of recent advances in the prevention and management of CHD in diabetic patients and the background behind it.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2009) conducted a review in Coronary Heart Disease and Diabetes. Screening Guidelines was evaluated. This review summarizes current guidelines from major societies on screening for coronary heart disease in patients with diabetes and detecting metabolic diseases in patients with coronary heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: